[1] El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis . Gastroenterology, 2007,132: 2557-2576. [2] 刘军, 厉天瑜, 张宁, 等. IL-1β诱导的miR-425表达上调对胃癌细胞生长的影响. 中华医学杂志, 2014, 94: 1889-1893. [3] Zhang X, Wu M, Chong QY, et al. Amplification of hsa-miR-191/425 locus promotes breast cancer proliferation and metastasis by targeting DICER1 . Carcinogenesis, 2018, 39: 1506-1516. [4] Su H, Yang JR, Xu T, et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity . Cancer Res, 2009, 69: 1135-1142. [5] Callegari E, Gramantieri L, Domenicali M, et al. MicroRNAs in liver cancer: A model for investigating pathogenesis and novel therapeutic approaches . Cell Death Differ, 2015, 22: 46-57. [6] Gramantieri L, Ferracin M, Fornari F, et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma . Cancer Res, 2007, 67: 6092-6099. [7] Meng F, Henson R, Wehbe-Janek H, et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer . Gastroenterology, 2007, 133: 647-658. [8] Lin CJ, Gong HY, Tseng HC, et al. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines . Biochem Biophys Res Commun, 2008, 375: 315-320. [9] 中国抗癌协会肝癌专业委员会,中国抗癌协会临床肿瘤学协作委员会,中华医学会肝病学分会肝癌学组. 原发性肝癌规范化诊治专家共识. 临床肿瘤学杂志, 2009, 14: 259-269. [10] Lee EJ, Rath P, Liu J, et al. Identification of global DNA methylation signatures in glioblastoma-derived cancer stem cells . J Genet Genomics, 2015, 42: 355-371. [11] 张彦,陆伟. Ki67在HBV相关肝细胞癌病理组织中的表达及其临床意义.天津医药,2015:929-931. [12] Sorokin AV, Nair BC, Wei Y, et al. Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis . Cancer Res, 2015,75: 1846-1858. |